DocGo Inc. Net Income (Loss) Allocated to General Partners
DocGo Inc. (DCGO) reported Net Income (Loss) Allocated to General Partners of $38.16 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NetIncomeLossAllocatedToGeneralPartners · last filed 2023-03-14
- DocGo Inc. net income (loss) allocated to general partners for fiscal 2022 was $38.16M, a 1.49% decline from fiscal 2021.
- DocGo Inc. net income (loss) allocated to general partners for fiscal 2021 was $38.74M.
| Period end | Net Income (Loss) Allocated to General Partners 12 month |
|---|---|
| 2022-12-31 | $38.16M 10-K · filed 2023-03-14 |
| 2021-12-31 | $38.74M 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |